InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.96
(
0.51%
)
US TECH 100
19,406.80
(
0.74%
)
Dow Jones
42,180.50
(
0.40%
)
Brent Oil
78.94
(
1.45%
)
Bitcoin
62,086.08
(
2.19%
)
Post# of 253276
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: poorgradstudent post# 2773

Thursday, 07/08/2004 5:46:30 PM

Thursday, July 08, 2004 5:46:30 PM

Post# of 253276
Avastin failed in 3rd line MBC.

Avastin has failed in 3rd line CRC as well.

Avastin has shown activity in MBC, NSCLC, RCC, pancreatic cancer, MDS, NHL

Avastin succeeded with flying colors in 1st line CRC


Is it unreasonable to believe that Avastin will pass the muster in 1st line MBC?

we are now speaking semantics, but if the potential market for a new indication is over 250 million, I consider that pipeline material.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up